Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma

by Lee, N.P., Poon, R.T.P., Shek, F.H., Ng, I.O.L., Luk, J.M.
Published 2016

MiR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma

by Liu, A.M., Xu, Z., Shek, F.H., Wong, K.-F., Lee, N.P., Poon, R.T., Chen, J., Luk, J.M.
Published 2014

Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma

by Wang Y., Shek F.H., Wong K.F., Liu L.X., Zhang X.Q., Yuan Y., Khin E., Hu M.-Y., Wang J.H., Poon R.T.P., Hong W., Lee N.P., Luk J.M.
Published 2019

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival

by Luk, J.M., Burchard, J., Zhang, C., Liu, A.M., Wong, K.F., Shek, F.H., Lee, N.P., Fan, S.T., Poon, R.T., Ivanovska, I., Philippar, U., Cleary, M.A., Buser, C.A., Shaw, P.M., Lee, C.-N., Tenen, D.G., Dai, H., Mao, M.
Published 2014